These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 30723672)

  • 41. Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures.
    de Biase S; Gigli GL; Nilo A; Romano G; Valente M
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):93-102. PubMed ID: 30577702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel treatment options for epilepsy: focus on perampanel.
    Franco V; Crema F; Iudice A; Zaccara G; Grillo E
    Pharmacol Res; 2013 Apr; 70(1):35-40. PubMed ID: 23287426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures.
    Ko D; Ramsay RE
    Acta Neurol Scand Suppl; 2013; (197):36-43. PubMed ID: 23480155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R
    Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
    Tabaee Damavandi P; Pasini F; Fanella G; Cereda GS; Mainini G; DiFrancesco JC; Trinka E; Lattanzi S
    Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epilepsy: Five new things.
    Saipetch C; Sachs E; Haneef Z
    Neurol Clin Pract; 2016 Oct; 6(5):444-451. PubMed ID: 29443283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perampanel in lissencephaly-associated epilepsy.
    Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Koichihara R
    Epilepsy Behav Case Rep; 2019; 11():67-69. PubMed ID: 30723672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 50. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures.
    Besag FM; Patsalos PN
    Neuropsychiatr Dis Treat; 2016; 12():1215-20. PubMed ID: 27274257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
    Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
    Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.